𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis

✍ Scribed by Hiroshi Miyakawa; Eriko Kitazawa; Kazuhiro Abe; Naomi Kawaguchi; Hirotoshi Fuzikawa; Kentaro Kikuchi; Makoto Kako; Tatsuji Komatsu; Naoaki Hayashi; Kendo Kiyosawa

Publisher
Springer Japan
Year
1997
Tongue
English
Weight
915 KB
Volume
32
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic active hepatitis associated with
Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis
✍ Jean-Claude Homberg; Nisen Abuaf; Olivier Bernard; Shamsul Islam; Fernando Alvar 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 740 KB

Sixty-five patients with histologically proven chronic active hepatitis of unknown cause but associated with the antiliver/kidney microsome antibody type 1, confirmed by immunofluorescence and immunoprecipitation, were selected as forming a special entity. This disease was found to be rare with a pr

Long term response to interferon treatme
Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers
✍ Depraetere, Stany; Van Kerschaever, Els; Van Vlierberghe, Hans; Elewaut, Andr�; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Interferon (IFN) alfa has been used widely for the treatment of chronic hepatitis C virus (HCV) infections but only a small number of patients treated have shown a sustained biochemical and virological response. Anti-envelope E1 and E2 antibody titers were assessed retrospectively before, during, an

Early antibody response against hypervar
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus
✍ A Zibert; H Meisel; W Kraas; A Schulz; G Jung; M Roggendorf 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

Antibodies directed to hypervariable region 1 (HVR1) of hepatitis C virus (HCV) have recently been shown to neutralize the corresponding HCV isolate in vitro. We analyzed the appearance of antibodies directed to HVR1 during the course of infection in a large group of patients who have been infected

Diagnosis of hepatitis C virus-associate
Diagnosis of hepatitis C virus-associated chronic liver disease in India: Comparison of HCV antibody assay with a polymerase chain reaction for the 5′ noncoding region
✍ Aswini K. Panigrahi; Santosh K. Nanda; Rajesh K. Dixit; Subrat K. Acharya; Arie 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

## Abstract The relative value of an anti‐hepatitis C virus (HCV) serological assay and reverse transcriptase‐nested polymerase chain reaction assays (RT‐PCR) were investigated for the constant 5′ putative noncoding region of HCV for the diagnosis of HCV‐associated chronic liver diseases in India.

A mutation in the interferon sensitivity
A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b
✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon